Human medicines European public assessment report (EPAR): Copalia HCT, amlodipine,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 28, Status: Authorised
Annual fees payable to the European Medicines Agency
Agenda - Combination products operational group, In vitro diagnostics (IVD) stream, 9 February 2026
Agenda - Combination products operational group, Medical devices (MD) stream, 12 February 2026
Webinar on the use of platform technologies in the non-clinical and clinical domains, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 March 2026, 09:25 (CET) to 2 March 2026, 12:15 (CET)
Overview of (invented) names reviewed in November 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 11 December 2025
Drug Shortages Global Regulatory Working Group
Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Date of authorisation: 25/06/2020, Revision: 7, Status: Authorised
Agenda - Webinar on the use of platform technologies in the non-clinical and clinical domains
LinkedIn Live: How EMA supports innovation in medicine development, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 February 2026, 14:30 (CET) to 25 February 2026, 15:00 (CET)